PALO ALTO, Calif.--(BUSINESS WIRE)--Science Exchange, the world’s leading and most secure enterprise platform for outsourced research and development (R&D) services, announced a partnership with Rapid Novor Inc. to offer its REmAb™ Antibody Protein Sequencing Services to scientists around the world using Science Exchange’s R&D platform.
Rapid Novor Inc. is a Kitchener-Waterloo based CRO dedicated to the development of antibody protein sequencing technologies. The company's mission is to advance life science research to better human health with next-generation protein sequencing. With the opening of its own state-of-the-art mass spectrometry lab in 2017, the team has successfully sequenced hundreds of monoclonal antibodies directly from the proteins and helped pharmaceutical companies in their antibody drug discovery.
"Our focus is on the development of antibody protein sequencing technologies, and we are the only team that has both a mass spectrometry lab and proprietary sequencing software platform," said Mingjie Xie, Co-founder and CEO of Rapid Novor Inc. "We are uniquely positioned to offer superior protein sequencing services to researchers worldwide. The partnership with Science Exchange will allow us to provide easy-to-access services to enterprise biopharma companies and offer them cutting-edge technologies in a seamless manner."
“We are thrilled to partner with Rapid Novor Inc. to make its REmAb™ Antibody Protein Sequencing Services available to scientists worldwide,” said Elizabeth Iorns, Ph.D., co-founder and CEO of Science Exchange. "By partnering with the leading CROs in different research and technology sectors, we are bringing in the best and brightest service providers to our secure and readily available platform so that the scientists can focus on developing breakthrough discoveries. Having Rapid Novor Inc. as part of our supplier portfolios is an example of our commitment to making it easy for researchers to access the world’s leading scientific service providers and most innovative scientific technologies."
About Rapid Novor Inc.
Rapid Novor Inc. is the world's
leader in antibody protein sequencing technology. Specializing in the
field of mass spectrometry-based proteomics, the team has developed the
technology to directly sequence the antibody proteins without needs to
access the cell line. As a University of Waterloo spin-off, the company
is building its technology portfolios based on the twenty years of
scientific research and inventions from Dr. Bin Ma, co-founder and chief
scientist. The company's REmAb™ antibody protein sequencing service has
allowed the accurate sequencing of any given antibody proteins
routinely. The company's WILD™ service is the first commercially
available service that can accurately distinguish the isomeric
Isoleucine and Leucine using mass spectrometry. For more information,
visit www.rapidnovor.com.
Follow the company on Twitter @rapidnovor.
About Science Exchange
Science Exchange is the world's
leading and most secure platform for outsourced research, providing an
efficient procure-to-pay platform for ordering 6,000+ services from a
network of more than 2,500 qualified scientific service providers, all
with pre-established contracts in place that protect client intellectual
property and confidentiality. The platform increases access to
innovation and improves productivity, freeing scientists from
administrative tasks and delays associated with sourcing, establishing
and managing service provider contracts. Additionally, the Science
Exchange enterprise program enables large R&D organizations to
consolidate research outsourcing spend into a single strategic
relationship, driving efficiency, improving transparency and oversight,
and delivering cost savings. Since being founded in 2011, Science
Exchange has raised more than $58 million from Norwest Venture Partners,
Maverick Capital Ventures, Union Square Ventures, Collaborative Fund,
Index Ventures, OATV, the YC Continuity Fund, and others. For more
information, visit www.ScienceExchange.com.
Follow the company on Twitter @ScienceExchange.